跳至主要内容
临床试验/ACTRN12620000381987
ACTRN12620000381987尚未招募未知

A brief illness perception intervention to improve adherence and glycemic control in patients with type 2 diabetes: A randomised controlled trial

Professor Elizabeth Broadbent0 个研究点目标入组 126 人开始时间: 2020年3月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients with poorly controlled type 2 diabetes will be included in this trial if they are (1) over 18 years of age (2) have type 2 diabetes for 1 year and longer (3) have poor glycaemic control (defined as glycosylated haemoglobin (A1c) concentration greater than or equal to 64 mmol/mol or 8% in the last two readings), and (4) are prescribed Metformin.
  • Any participating family members will have to be over the age of 18 years.

排除标准

  • Patients will be excluded if they are (1) pregnant (2) have life-threatening illness (e.g. cancer), and (3) not prescribed Metformin.

研究者

发起方
Professor Elizabeth Broadbent

相似试验